APPLICATION
ANDA070655
TYPE
ANDA
ORIGINAL APPROVAL
1987-10-01
LATEST ACTION
2010-01-08
ROUTE
ORAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued
Products
FUROSEMIDEDiscontinued
FUROSEMIDE 10MG/ML · SOLUTION · ORAL
Approval history
2010-01-08Labeling · Supplement 16AP
2009-11-16Labeling · Supplement 15AP
2004-02-13Labeling · Supplement 12AP
1997-03-03Labeling · Supplement 10AP
1996-03-15Labeling · Supplement 9AP
1994-08-04Labeling · Supplement 8AP
1992-04-06Labeling · Supplement 7AP
1992-01-16Labeling · Supplement 6AP
1991-06-05Labeling · Supplement 5AP
1990-10-24Labeling · Supplement 4AP
1990-04-03Labeling · Supplement 2AP
1990-04-03Labeling · Supplement 3AP
1989-01-25Labeling · Supplement 1AP
1987-10-01OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.